GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.83 $2.75 Friday, 19th Apr 2024 CGEN stock ended at $1.90. This is 1.06% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 7.36% from a day low at $1.84 to a day high of $1.97.
90 days $1.80 $3.03
52 weeks $0.530 $3.03

Historical Compugen Ltd. prices

Date Open High Low Close Volume
2021-02-12 $12.87 $13.23 $12.73 $13.13 643 856
2021-02-11 $13.18 $13.39 $12.66 $13.01 706 280
2021-02-10 $13.91 $14.08 $12.87 $13.13 778 177
2021-02-09 $13.89 $14.17 $13.46 $13.47 1 072 908
2021-02-08 $13.37 $14.00 $13.34 $13.77 1 299 446
2021-02-05 $12.80 $13.11 $12.52 $12.97 766 278
2021-02-04 $12.93 $13.30 $12.48 $12.53 959 787
2021-02-03 $13.67 $13.74 $12.87 $12.88 791 342
2021-02-02 $13.15 $13.88 $13.15 $13.49 1 305 907
2021-02-01 $12.47 $13.18 $12.39 $13.04 1 142 820
2021-01-29 $12.09 $12.48 $11.76 $12.16 772 321
2021-01-28 $11.66 $12.25 $11.57 $12.00 994 240
2021-01-27 $12.32 $12.34 $11.31 $11.44 1 426 965
2021-01-26 $12.71 $12.90 $12.34 $12.39 734 920
2021-01-25 $12.63 $12.97 $12.27 $12.65 787 190
2021-01-22 $12.66 $12.83 $12.32 $12.54 799 241
2021-01-21 $13.55 $13.78 $12.61 $12.64 1 092 789
2021-01-20 $13.69 $14.11 $13.22 $13.26 1 311 203
2021-01-19 $13.20 $13.72 $13.15 $13.50 1 208 809
2021-01-15 $13.57 $14.22 $13.00 $13.01 1 134 512
2021-01-14 $13.31 $13.98 $13.31 $13.51 1 249 276
2021-01-13 $12.84 $13.75 $12.84 $13.41 1 368 394
2021-01-12 $12.71 $12.93 $12.54 $12.81 867 841
2021-01-11 $12.89 $12.96 $12.26 $12.62 1 360 047
2021-01-08 $13.24 $14.30 $13.12 $13.32 2 077 751
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT